ZRO Biosenta Inc

Biosenta Announces Record Revenues

Biosenta Announces Record Revenues

CALGARY, Alberta, Jan. 26, 2021 (GLOBE NEWSWIRE) -- Today, Biosenta realized its first purchase order and payment from the supply and purchase agreement with SANITIZATION 360. The Purchase Order is for an initial order of 145 drums (30,160 litres) of TRUE disinfectant and continued monthly orders.

This marks a milestone for Biosenta of achieving record revenues as it continues to implement its strategic plan to position the company to be a leader in the growing disinfectant market in North America. The agreement with SANITIZATION 360 is a perfect fit for Biosenta’s growth plans and aligns itself with a company that sells leading edge disinfectants products.

About SANITIZATION 360

SANITIZATION 360 is a Canadian sanitization and disinfectant company with leading-edge products to combat viruses and bacteria.

About Biosenta

Biosenta develops and manufactures a range of wet and dry anti-microbial chemical compounds for household and industrial applications using active material, and advanced encapsulated nanotechnology.

Disclaimer

In no way, the CSE has passed upon the contents of this news release and further has neither approved nor disapproved of the contents of this news release. Neither the CSE nor its Regulation Services Provider (as such term is defined in the CSE) accepts responsibility for this release's adequacy or accuracy.

Biosenta Digital channel:

Contact Information:

Am Gill

President and CEO

T: 416-410-2019

For further information on the project,

please contact: 



Sales

Biosenta Inc.

34 Wrangler Place, Suite 10

Rocky View County, Alberta T1X 0L7

T: 416-410-2019

E:
     For Investor Relations, 

please contact: 



Investor Relations

Biosenta Inc.

18 Wynford Drive, Suite 704

Toronto, Ontario M3C 3S2

T: 416-410-2019

E:
   


EN
26/01/2021

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Biosenta Inc

 PRESS RELEASE

Biosenta Announces Breakthrough Discovery in Anti-Microbial Efficacy o...

Biosenta Announces Breakthrough Discovery in Anti-Microbial Efficacy of Tri-Filler™ in Collaboration with Dr. Ian Lewis and Dr. Maen Husein's Labs TORONTO and CALGARY, Alberta, Sept. 28, 2023 (GLOBE NEWSWIRE) -- Biosenta Inc. (“Biosenta” or the “Company”) (CSE: ZRO) is thrilled to announce a pivotal discovery led by Dr. Mehdi Mohammadi Ashani, a Postdoctoral Researcher under the mentorship of Dr. Ian Lewis and Dr. Maen Husein at the University of Calgary. Utilizing the advanced capabilities of the Alberta Centre for Advanced Diagnostics (ACAD), this research has revealed that Tri-Filler™,...

 PRESS RELEASE

Biosenta builds on partnership with AMPAK to test and commercialize Tr...

Biosenta builds on partnership with AMPAK to test and commercialize Tri-Filler™ CALGARY, Alberta, Sept. 06, 2023 (GLOBE NEWSWIRE) -- Biosenta Inc. (“Biosenta” or the “Company”) listed on the CSE (CSE: ZRO) is pleased to announce the next level of partnership with AMPAK Inc. and the University of Calgary. The new Agreement will see Tri-Filler™ being tested in plastics at AMPAK Inc. facilities with an eye to commercialization. Further to the announcement of the partnership on September 24th, 2020, AMPAK Inc. has signed a new agreement with Biosenta and the University of Calgary that will g...

 PRESS RELEASE

Biosenta announces further advances in research and development of Tri...

Biosenta announces further advances in research and development of Tri-Filler™ TORONTO and CALGARY, Alberta, Aug. 08, 2023 (GLOBE NEWSWIRE) -- Biosenta Inc. (“Biosenta” or the “Company”) (CSE: ZRO) is pleased to announce further advances in research and development of the Tri-Filler™ particle composed of Ca(OH)2 (calcium hydroxide) core with a CaCO3 (calcium carbonate) encapsulation. Ongoing development of new methods of production of Tri-Filler™ by Dr. Maen Husein of the Department of Chemical Engineering at the University of Calgary and his team have reduced aggregation and resulted in ...

 PRESS RELEASE

Biosenta Inc. ceases negotiations with Voran Group Ventures Ltd.

Biosenta Inc. ceases negotiations with Voran Group Ventures Ltd. CALGARY, Alberta, May 31, 2023 (GLOBE NEWSWIRE) -- Biosenta Inc. ( “Biosenta”) (CSE: ZRO) announces that, further to its news release dated October 12, 2022, it has ceased negotiations with Voran Group Ventures Ltd. in respect of the previously announced Memorandum of Understanding dated October 5, 2022, for the commercialization of Biosenta’s Tri-Filler® antimicrobial products in Canadian markets and worldwide. About Biosenta Inc. Biosenta is a Canadian-based company that develops and manufactures a range of safe and envi...

 PRESS RELEASE

Biosenta Inc. Enters into an MOU with Voran Group Ventures Ltd. to col...

Biosenta Inc. Enters into an MOU with Voran Group Ventures Ltd. to collaborate on the commercialization of Biosenta’s Tri-Filler® Products CALGARY, Alberta, Oct. 12, 2022 (GLOBE NEWSWIRE) -- Biosenta Inc. (the “Company” or “Biosenta”) (CSE: ZRO) has signed a milestone Memorandum of Understanding dated October 5, 2022, with VORAN GROUP VENTURES Ltd. (“Voran”) which will lead the way for the commercialization of Biosenta’s Tri-Filler® antimicrobial products in Canadian markets and worldwide. The patented new material science Tri-Filler® products could set the new standard in antimicrobial ...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch